Does Wegovy Make You Moody or Affect Your Mental Health?

What the STEP trials and regulator guidance actually recorded

The large STEP 1 trial (68 weeks, semaglutide 2.4mg against placebo, published in the New England Journal of Medicine) tracked a wide range of adverse events in nearly 2,000 adults. The dominant side-effect signal was gastrointestinal: nausea, vomiting, and similar complaints were far more common than any mood-related report. Mood disturbance did not emerge as a statistically prominent finding in that cohort, but trial populations are selected and monitored carefully, which limits how much they tell us about real-world variability.

The MHRA's patient information for Wegovy lists depression, low mood, and thoughts of self-harm under effects that require urgent medical attention if they arise. This is a precautionary signal, not a confirmation that these effects are common — regulators apply this level of caution to many medicines that touch appetite and body weight, because those systems interact with mood in ways that are not yet fully mapped. The NHS medicines page on semaglutide reflects this: it advises telling a doctor straight away if you notice changes in mood or have thoughts of harming yourself, while not describing these as typical effects.

Irritability in the early weeks may also have an indirect cause: nausea, disrupted eating patterns, and fatigue can all affect how someone feels day to day, without the medicine acting directly on mood at all. If you are finding the early weeks difficult, it is worth reading about tiredness and energy changes on Wegovy alongside the mood question, since the two often travel together.

Could semaglutide actually improve mood for some people?

This is where the science becomes genuinely interesting, and genuinely unresolved. GLP-1 receptors are present not only in the gut and pancreas but in areas of the brain involved in reward, motivation, and emotional regulation. Researchers have been investigating whether activating these receptors might have mood-relevant effects beyond weight loss itself.

Several observational analyses have found that people using GLP-1 medicines report improvements in quality of life and, in some measures, mood, but these studies are difficult to interpret cleanly. Losing a meaningful amount of weight has its own well-documented positive effects on self-esteem, mobility, and energy; separating those from any direct neurological effect of the medicine is methodologically hard. The NICE appraisal of semaglutide for weight management, TA875, does not draw conclusions about mood as a standalone outcome, focusing instead on cardiovascular and metabolic endpoints.

What this means practically: some people find their mood lifts on Wegovy, others notice a dip, and many report no change at all. Both directions of experience are plausible given what we know. If you are already living with depression or anxiety, your mental health history will be part of the clinical assessment before any treatment is started, a prescriber who reviews notes carefully rather than ticking a box is the right safeguard here. Our team's approach to that review is described on the about us page.

Practical steps if you notice mood changes on Wegovy

Mood shifts that feel new, persistent, or distressing deserve prompt attention. The threshold for contacting your prescriber or GP should be low. You do not need to wait for your next scheduled check-in; if something feels wrong, that is enough reason to reach out. The same applies to a carer or family member who notices a change in you that you might not have registered yourself.

A few things worth noting alongside the mood question. Eating less (particularly if protein or calorie intake drops sharply) can affect energy and concentration in ways that feel mood-adjacent. Staying hydrated matters more than many people expect, especially if nausea has been making eating or drinking difficult. Some people find that keeping the pen in the fridge door, next to the everyday basics, helps them stick to a routine, which in itself reduces the low-level anxiety that can come from forgetting a dose or losing track of where you are in the schedule.

If you want to report a suspected side effect, including mood changes, the MHRA's Yellow Card scheme accepts reports directly from patients, not just clinicians. These reports feed into the ongoing post-market safety monitoring that keeps guidance current.

Wegovy sits alongside other semaglutide side effects that are worth understanding before starting treatment. Gastrointestinal symptoms like nausea and queasiness are far more common, and knowing the full picture helps you recognise what is expected and what needs attention. For a broader look at treatment options and how Wegovy fits into them, the weight-loss treatment overview is a useful starting point. Cost context, should you want it, is covered on the Wegovy price comparison page.

If mood changes are a concern for you personally (either as a current user or as someone considering starting) that is exactly the kind of conversation our prescribers are there for. Start your free consultation and a GPhC-registered clinician will review your history, including your mental health background, before anything is prescribed.